Insider Buying: Beta Bionics, Inc. (NASDAQ:BBNX) Insider Buys 33,350 Shares of Stock

Beta Bionics, Inc. (NASDAQ:BBNX) insider Mike Mensinger bought 33,350 shares of the firm’s stock in a transaction dated Friday, January 31st. The shares were acquired at an average price of $17.00 per share, for a total transaction of $566,950.00. Following the acquisition, the insider now directly owns 59,019 shares of the company’s stock, valued at approximately $1,003,323. The trade was a 129.92 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

Beta Bionics Price Performance

Beta Bionics stock traded down $1.06 during midday trading on Monday, reaching $22.75. The stock had a trading volume of 693,779 shares, compared to its average volume of 793,990. Beta Bionics, Inc. has a 1-year low of $22.00 and a 1-year high of $24.50.

About Beta Bionics

We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.